Table 3.

Pain scores post-procedure in childhood arthritis by treatment group

	Male (n = 19)			Female (n = 44)
	EMLA® or Numby® (n = 9)	EMLA® or Numby® + Subcutaneous Buffered Lidocaine (n = 10)	P-value	EMLA® or Numby® (n = 19)	EMLA® or Numby® + Subcutaneous Buffered Lidocaine (n = 25)	P-value
All patients (63)
FPS-R (63)	2.0 (2.0–2.0)	1.5 (0.0–4.0)	0.64	5.0 (2.0–6.0)	2.0 (2.0–4.0)	0.03*
FLACC (56)	0.0 (0.0–1.0)	1.0 (0.0–2.0)	0.53	2.5 (0.0–6.0)	0.0 (0.0–3.0)	0.02*
PGA (61)	2.0 (1.0–2.0)	0.5 (0.0–2.0)	0.37	2.0 (1.0–5.0)	0.0 (0.0–2.0)	0.01*
Oligoarthritis patients (49)
FPS-R (49)	2.0 (2.0–4.0)	1.0 (0.0–2.0)	0.25	6.0 (2.0–6.0)	2.0 (2.0–4.0)	0.06
FLACC (42)	1.0 (0.0–1.0)	1.0 (0.0–4.0)	0.74	3.5 (0.5–7.0)	0.0 (0.0–2.0)	0.01*
PGA (48)	2.0 (1.0–2.0)	1.5 (0.0–2.0)	0.54	2.0 (1.0–3.0)	0.0 (0.0–1.0)	0.01*

Pain scores are reported as Median (IQR: 25^th-75^th percentiles); IQR = inter quartile range, FPS-R = Faces Pain Scale-Revised, FLACC = Faces, Leg, Affect, Cry, Consolability scale, PGA = parental global assessment. Two- sided Wilcoxon Rank Sum Test was used to compare pain scores between groups. *P < 0.05 was considered statistically significant